Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:24 PM
Ignite Modification Date:
2025-12-24 @ 3:24 PM
NCT ID:
NCT03358992
Eligibility Criteria:
Inclusion Criteria:
* 1\) histologically confirmed high-grade osteosarcoma;
* 2\) initially treated in Musculoskeletal Tumor Center of Peking University People's Hospital, Xijing Hospital or The Second Hospital affiliated to Zhejiang Hospital;
* 3\) imaging evaluation should be available;
* 4\) completed neo-adjuvant chemotherapy and at least 8 cycles of adjuvant chemotherapy;
* 5\) expected to live longer than 3 months with Eastern Cooperative Oncology Group performance status of 0 or 1;
* 6\) acceptable hematologic, hepatic, and renal function.
Exclusion Criteria:
* 1\) Patients who could not complete neo-adjuvant chemotherapy or at least 4-month adjuvant chemotherapy;
* 2\) lost to follow-up.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT03358992
Study Brief:
Protocol Section:
NCT03358992